DK1084230T3 - Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller - Google Patents
Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamcellerInfo
- Publication number
- DK1084230T3 DK1084230T3 DK99955496T DK99955496T DK1084230T3 DK 1084230 T3 DK1084230 T3 DK 1084230T3 DK 99955496 T DK99955496 T DK 99955496T DK 99955496 T DK99955496 T DK 99955496T DK 1084230 T3 DK1084230 T3 DK 1084230T3
- Authority
- DK
- Denmark
- Prior art keywords
- stem cells
- hematopoietic stem
- mesenchymal stem
- regulation
- human mesenchymal
- Prior art date
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 title abstract 5
- 210000002901 mesenchymal stem cell Anatomy 0.000 title abstract 4
- 230000024245 cell differentiation Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 230000004069 differentiation Effects 0.000 abstract 2
- 210000002997 osteoclast Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 210000000963 osteoblast Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0643—Osteoclasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1358—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/18—Calcium salts, e.g. apatite, Mineral components from bones, teeth, shells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8843198P | 1998-06-08 | 1998-06-08 | |
| US9923398P | 1998-09-04 | 1998-09-04 | |
| PCT/US1999/012847 WO1999064565A2 (en) | 1998-06-08 | 1999-06-08 | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1084230T3 true DK1084230T3 (da) | 2008-03-03 |
Family
ID=26778653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99955496T DK1084230T3 (da) | 1998-06-08 | 1999-06-08 | Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6255112B1 (da) |
| EP (1) | EP1084230B1 (da) |
| JP (1) | JP2003505006A (da) |
| AT (1) | ATE375799T1 (da) |
| AU (1) | AU4336499A (da) |
| CA (2) | CA2330190C (da) |
| CY (1) | CY1107121T1 (da) |
| DE (1) | DE69937347T2 (da) |
| DK (1) | DK1084230T3 (da) |
| ES (1) | ES2296413T3 (da) |
| PT (1) | PT1084230E (da) |
| WO (1) | WO1999064565A2 (da) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021766A2 (en) * | 1999-09-23 | 2001-03-29 | Cell Science Therapeutics | Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| WO2002040639A2 (en) * | 2000-11-14 | 2002-05-23 | The University Of Louisville Research Foundation, Inc. | Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| AU2020902A (en) | 2000-12-06 | 2002-06-18 | Robert J Hariri | Method of collecting placental stem cells background of the invention |
| EP2316918B1 (en) | 2001-02-14 | 2015-07-01 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| NZ528035A (en) | 2001-02-14 | 2005-07-29 | Robert J Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| CA2456607A1 (en) * | 2001-08-08 | 2003-02-20 | Schering Corporation | Uses of mammalian cytokine; related reagents |
| US7700090B2 (en) | 2002-02-13 | 2010-04-20 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
| CA2477411A1 (en) * | 2002-03-02 | 2003-09-12 | Board Of Regents, The University Of Texas | Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| EP1525308A4 (en) * | 2002-05-30 | 2006-11-02 | Celgene Corp | METHODS OF USING JNK OR MKK INHIBITORS TO MODULATE CELL DIFFERENTIATION AND TREAT MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASIC SYNDROMES |
| US20040028661A1 (en) * | 2002-08-07 | 2004-02-12 | Bartelmez Stephen H. | Expansion of cells using thrombopoietin and anti-transforming growth factor-beta |
| KR101042448B1 (ko) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법 |
| CA2521217C (en) * | 2003-04-01 | 2013-05-14 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| WO2004092402A1 (en) * | 2003-04-15 | 2004-10-28 | Pfizer Inc. | Dual reporter/dye reduction methodology for evaluating antiviral activity and cytotoxicity of hepatitis c virus inhibitors |
| EP1479760A1 (de) * | 2003-05-19 | 2004-11-24 | ProBioGen AG | Künstliches Immunorgan |
| EP2450433A3 (en) | 2003-10-08 | 2012-08-08 | Vet-Stem Inc | Methods of preparing and using stem cell compositions and kits comprising the same |
| US20050112551A1 (en) * | 2003-11-24 | 2005-05-26 | Agouron Pharmaceuticals, Inc. | Dual assay for evaluating activity and cytotoxicity of compounds in the same population of cells |
| EP1799812A4 (en) | 2004-09-16 | 2009-09-09 | Gamida Cell Ltd | EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS |
| CA2512667A1 (en) * | 2005-01-07 | 2006-07-07 | Takahiro Ochiya | Human hepatocyte-like cells and uses thereof |
| US20080241112A1 (en) * | 2005-05-10 | 2008-10-02 | Christof Westenfelder | Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media |
| WO2007047468A2 (en) | 2005-10-13 | 2007-04-26 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
| US8846393B2 (en) * | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
| PL2471905T3 (pl) | 2005-12-29 | 2019-08-30 | Celularity, Inc. | Populacje komórek macierzystych łożyska |
| MX2008015645A (es) * | 2006-06-09 | 2009-02-06 | Anthrogenesis Corp | Nicho placentario y uso de este para cultivar celulas primordiales. |
| US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
| KR100818213B1 (ko) | 2006-09-22 | 2008-04-01 | 재단법인서울대학교산학협력재단 | 파골세포 기반 적소 유사 구조에 의해 증식능이 증가된인간 제대혈 유래 다분화능 줄기 세포 및 그 제조방법 |
| US20080118477A1 (en) * | 2006-11-09 | 2008-05-22 | Rush University Medical Center | Umbilical cord mesenchymal stem cells support cord blood hematopoiesis |
| CN101688177A (zh) | 2007-02-12 | 2010-03-31 | 人类起源公司 | 来自贴壁胎盘干细胞的肝细胞和软骨细胞；以及cd34+、cd45-胎盘干细胞富集的细胞群 |
| JP5979811B2 (ja) | 2007-02-12 | 2016-08-31 | アンスロジェネシス コーポレーション | 胎盤幹細胞を使用した炎症性疾患の治療 |
| US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
| CN101173247B (zh) * | 2007-08-08 | 2010-06-02 | 中国人民解放军军事医学科学院基础医学研究所 | 一种利用间充质干细胞联合细胞因子培养破骨细胞的方法 |
| NZ599825A (en) | 2007-09-28 | 2014-10-31 | Anthrogenesis Corp | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| KR20170023194A (ko) | 2008-08-20 | 2017-03-02 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
| KR20200143506A (ko) | 2008-08-20 | 2020-12-23 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
| RU2011110736A (ru) | 2008-08-22 | 2012-09-27 | Антродженезис Корпорейшн (Us) | Способы и композиции для лечения костных дефектов с помощью плацентарных клеточных популяций |
| CN107201337A (zh) | 2008-11-19 | 2017-09-26 | 人类起源公司 | 羊膜来源的贴壁细胞 |
| NZ597436A (en) | 2009-07-02 | 2014-08-29 | Anthrogenesis Corp | Method of producing erythrocytes without feeder cells |
| US20120177618A1 (en) * | 2009-07-14 | 2012-07-12 | Massachusetts Institute Of Technology | Hematopoietic stromal progenitor cells and uses thereof |
| WO2011090221A1 (en) | 2010-01-22 | 2011-07-28 | Kyoto University | Method for improving induced pluripotent stem cell generation efficiency |
| KR20120115602A (ko) | 2010-01-26 | 2012-10-18 | 안트로제네시스 코포레이션 | 태반 줄기 세포를 사용한 골 관련 암의 치료 |
| IL250234B2 (en) | 2010-04-07 | 2023-10-01 | Anthrogenesis Llc | Creating blood vessels using placental stem cells |
| WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
| ES2666746T3 (es) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Métodos para generar linfocitos citolíticos naturales |
| WO2012048276A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
| EP2647699B1 (en) | 2010-12-03 | 2020-04-01 | Kyoto University | Efficient method for establishing induced pluripotent stem cells |
| WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
| EP2714059B1 (en) | 2011-06-01 | 2018-10-03 | Celularity, Inc. | Treatment of pain using placental stem cells |
| US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
| EP2814950A1 (en) | 2012-02-13 | 2014-12-24 | Gamida-Cell Ltd. | Mesenchymal stem cells conditioned medium and methods of generating and using the same |
| US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
| US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
| WO2014123879A1 (en) | 2013-02-05 | 2014-08-14 | Anthrogenesis Corporation | Natural killer cells from placenta |
| EP3569699A1 (en) | 2013-09-04 | 2019-11-20 | Otsuka Pharmaceutical Factory, Inc. | Method for preparing pluripotent stem cells |
| EP3068867B1 (en) | 2013-11-16 | 2018-04-18 | Terumo BCT, Inc. | Expanding cells in a bioreactor |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| CN106715676A (zh) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | 按计划供养 |
| KR101566450B1 (ko) * | 2015-04-03 | 2015-11-05 | (유)스템메디케어 | 중간엽 줄기세포에서 단백질의 대량 생산 방법 |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | CELL EXPANSION |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| WO2022204315A1 (en) | 2021-03-23 | 2022-09-29 | Terumo Bct, Inc. | Cell capture and expansion |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399493A (en) * | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| DE4322570C1 (de) * | 1993-07-07 | 1994-06-16 | Gsf Forschungszentrum Umwelt | Stromale Zellinien aus menschlichem Knochenmark |
| US5719058A (en) * | 1995-04-10 | 1998-02-17 | Merck & Co., Inc. | Method for producing a highly enriched population of osteoclast cells |
-
1999
- 1999-06-08 DK DK99955496T patent/DK1084230T3/da active
- 1999-06-08 AT AT99955496T patent/ATE375799T1/de not_active IP Right Cessation
- 1999-06-08 CA CA002330190A patent/CA2330190C/en not_active Expired - Fee Related
- 1999-06-08 DE DE69937347T patent/DE69937347T2/de not_active Expired - Lifetime
- 1999-06-08 EP EP99955496A patent/EP1084230B1/en not_active Expired - Lifetime
- 1999-06-08 CA CA002680649A patent/CA2680649A1/en not_active Abandoned
- 1999-06-08 PT PT99955496T patent/PT1084230E/pt unknown
- 1999-06-08 AU AU43364/99A patent/AU4336499A/en not_active Abandoned
- 1999-06-08 WO PCT/US1999/012847 patent/WO1999064565A2/en active IP Right Grant
- 1999-06-08 ES ES99955496T patent/ES2296413T3/es not_active Expired - Lifetime
- 1999-06-08 US US09/327,796 patent/US6255112B1/en not_active Expired - Lifetime
- 1999-06-08 JP JP2000553555A patent/JP2003505006A/ja active Pending
-
2008
- 2008-01-02 CY CY20081100007T patent/CY1107121T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1084230E (pt) | 2008-01-25 |
| CA2330190C (en) | 2009-12-22 |
| WO1999064565A2 (en) | 1999-12-16 |
| JP2003505006A (ja) | 2003-02-12 |
| CY1107121T1 (el) | 2012-10-24 |
| WO1999064565A9 (en) | 2000-04-13 |
| ATE375799T1 (de) | 2007-11-15 |
| EP1084230A2 (en) | 2001-03-21 |
| DE69937347D1 (de) | 2007-11-29 |
| AU4336499A (en) | 1999-12-30 |
| US6255112B1 (en) | 2001-07-03 |
| CA2680649A1 (en) | 1999-12-16 |
| DE69937347T2 (de) | 2008-09-04 |
| WO1999064565A3 (en) | 2000-02-24 |
| ES2296413T3 (es) | 2008-04-16 |
| CA2330190A1 (en) | 1999-12-16 |
| EP1084230B1 (en) | 2007-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1084230T3 (da) | Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller | |
| WO2000006705A3 (de) | Genetisch modifizierte cd34-negative, adhärent wachsende stammzellen und deren verwendung in der gentherapie | |
| Conget et al. | Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells | |
| NO20022180D0 (no) | Hematopoietisk differensiering av humane embryoniske stamceller | |
| MX9206376A (es) | Liberacion de proteinas por terapia genica | |
| MY140230A (en) | Activating expression of an amplifying endogenous gene by homologous recombination | |
| FR2808803B1 (fr) | Cellules es modifiees et gene specifique de cellules es | |
| DE69737949D1 (de) | Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems | |
| Ogawa et al. | Chondrogenic and osteogenic differentiation of adipose-derived stem cells isolated from GFP transgenic mice | |
| AU2126688A (en) | Serum free media for the growth of insect cells and expression of products thereby | |
| ES2127458T3 (es) | Produccion de proteinas utilizando recombinacion homologa. | |
| EP0953354A4 (en) | HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES | |
| IL164817A (en) | Composition comprising near diploid immortalized keratinocytes cells | |
| ATE389022T1 (de) | Verstärkte herstellung rekombinanter proteine mittels transienter transfektion von in suspension wachsenden säugerzellen | |
| ATE217905T1 (de) | Zellinien, die einen biologisch aktiven faktor-ix exprimieren | |
| ATE243741T1 (de) | Zufuhr von genprodukten mittels mesangium-zellen | |
| EP0808364A4 (en) | HUMAN PANCREAS CELL LINES: DEVELOPMENTS AND APPLICATIONS | |
| GB2366291A (en) | A transformant for screening of inhibitors for human immnodeficiency virus | |
| AU4216599A (en) | Hematopoietic progenitor cell gene transduction | |
| Siemen et al. | Nucleofection of human embryonic stem cells | |
| by Electroporation et al. | Check for updates | |
| ATE374243T1 (de) | Knorpelzell-kulturmedium und verwendung desselben | |
| Sainova et al. | Experimental model for safe in vitro-and in vivo-influence of internal and external factors of cell differentiation | |
| DE69823813D1 (de) | Malignitätsunterdrückung durch verwendung von ribonucleotid reductase r1 | |
| Sainova et al. | In vitro-and in vivo-experimental models for balanced activity of oncogenes and tumor-suppressor genes in normal and malignant cells |